speb/financial-data huggingface dataset:
GUFICBIO.NS balance_sheet (annual, 2023-03-31) — Long Term Debt: 1906793000.00
GUFICBIO.NS balance_sheet (annual, 2023-03-31) — Long Term Debt And Capital Lease Obligation: 2068892000.00
GUFICBIO.NS cash_flow (annual, 2023-03-31) — Long Term Debt Issuance: 1074636000.00
GUFICBIO.NS balance_sheet (annual, 2023-03-31) — Long Term Provisions: 132945000.00
GUFICBIO.NS balance_sheet (annual, 2023-03-31) — Machinery Furniture Equipment: 1479395000.00
GUFICBIO.NS balance_sheet (annual, 2023-03-31) — Net Debt: 2828052000.00
GUFICBIO.NS income_statement (annual, 2023-03-31) — Net Income: 797048000.00
GUFICBIO.NS income_statement (annual, 2023-03-31) — Net Income Common Stockholders: 797048000.00
GUFICBIO.NS income_statement (annual, 2023-03-31) — Net Income Continuous Operations: 797048000.00
GUFICBIO.NS income_statement (annual, 2023-03-31) — Net Income From Continuing And Discontinued Operation: 797048000.00
GUFICBIO.NS income_statement (annual, 2023-03-31) — Net Income From Continuing Operation Net Minority Interest: 797048000.00
GUFICBIO.NS cash_flow (annual, 2023-03-31) — Net Income From Continuing Operations: 797048000.00
GUFICBIO.NS income_statement (annual, 2023-03-31) — Net Income Including Noncontrolling Interests: 797048000.00
GUFICBIO.NS income_statement (annual, 2023-03-31) — Net Interest Income: -68113000.00
GUFICBIO.NS cash_flow (annual, 2023-03-31) — Net Investment Purchase And Sale: -7768000.00
GUFICBIO.NS cash_flow (annual, 2023-03-31) — Net Issuance Payments Of Debt: 2500924000.00
GUFICBIO.NS cash_flow (annual, 2023-03-31) — Net Long Term Debt Issuance: 1074636000.00
GUFICBIO.NS income_statement (annual, 2023-03-31) — Net Non Operating Interest Income Expense: -68113000.00
GUFICBIO.NS cash_flow (annual, 2023-03-31) — Net Other Financing Charges: -2160000.00
GUFICBIO.NS cash_flow (annual, 2023-03-31) — Net Other Investing Changes: -33672000.00
GUFICBIO.NS balance_sheet (annual, 2023-03-31) — Net PPE: 3284788000.00
GUFICBIO.NS cash_flow (annual, 2023-03-31) — Net PPE Purchase And Sale: -1875691000.00
GUFICBIO.NS cash_flow (annual, 2023-03-31) — Net Short Term Debt Issuance: 1426288000.00
GUFICBIO.NS balance_sheet (annual, 2023-03-31) — Net Tangible Assets: 3471294000.00
GUFICBIO.NS balance_sheet (annual, 2023-03-31) — Non Current Deferred Revenue: 49601000.00
GUFICBIO.NS balance_sheet (annual, 2023-03-31) — Non Current Deferred Taxes Assets: 9664000.00
GUFICBIO.NS balance_sheet (annual, 2023-03-31) — Non Current Deferred Taxes Liabilities: 0.00
GUFICBIO.NS balance_sheet (annual, 2023-03-31) — Non Current Prepaid Assets: 658018000.00
GUFICBIO.NS income_statement (annual, 2023-03-31) — Normalized EBITDA: 1356075000.00
GUFICBIO.NS income_statement (annual, 2023-03-31) — Normalized Income: 796822450.46
GUFICBIO.NS cash_flow (annual, 2023-03-31) — Operating Cash Flow: -265872000.00
GUFICBIO.NS income_statement (annual, 2023-03-31) — Operating Income: 1153309000.00
GUFICBIO.NS income_statement (annual, 2023-03-31) — Operating Revenue: 6797546000.00
GUFICBIO.NS balance_sheet (annual, 2023-03-31) — Ordinary Shares Number: 96944506.00
GUFICBIO.NS balance_sheet (annual, 2023-03-31) — Other Current Assets: 8359000.00
GUFICBIO.NS balance_sheet (annual, 2023-03-31) — Other Current Liabilities: 125048000.00
GUFICBIO.NS balance_sheet (annual, 2023-03-31) — Other Equity Interest: 3381137000.00
GUFICBIO.NS balance_sheet (annual, 2023-03-31) — Other Intangible Assets: 6788000.00
GUFICBIO.NS cash_flow (annual, 2023-03-31) — Other Non Cash Items: 73909000.00
GUFICBIO.NS balance_sheet (annual, 2023-03-31) — Other Non Current Assets: 577111000.00
GUFICBIO.NS income_statement (annual, 2023-03-31) — Other Non Operating Income Expenses: 11312000.00
GUFICBIO.NS income_statement (annual, 2023-03-31) — Other Operating Expenses: 898715000.00
GUFICBIO.NS balance_sheet (annual, 2023-03-31) — Other Payable: 178923000.00
GUFICBIO.NS balance_sheet (annual, 2023-03-31) — Other Properties: 54606000.00
GUFICBIO.NS balance_sheet (annual, 2023-03-31) — Other Receivables: 2044000.00
GUFICBIO.NS balance_sheet (annual, 2023-03-31) — Other Short Term Investments: 180848000.00
GUFICBIO.NS income_statement (annual, 2023-03-31) — Other Special Charges: -302000.00
GUFICBIO.NS income_statement (annual, 2023-03-31) — Otherunder Preferred Stock Dividend: 0.00
GUFICBIO.NS balance_sheet (annual, 2023-03-31) — Payables: 1481794000.00
GUFICBIO.NS balance_sheet (annual, 2023-03-31) — Prepaid Assets: 274584000.00
GUFICBIO.NS income_statement (annual, 2023-03-31) — Pretax Income: 1067209000.00
GUFICBIO.NS balance_sheet (annual, 2023-03-31) — Properties: 0.00
GUFICBIO.NS cash_flow (annual, 2023-03-31) — Purchase Of Investment: -7768000.00
GUFICBIO.NS cash_flow (annual, 2023-03-31) — Purchase Of PPE: -1876007000.00
GUFICBIO.NS balance_sheet (annual, 2023-03-31) — Raw Materials: 792283000.00
GUFICBIO.NS income_statement (annual, 2023-03-31) — Reconciled Cost Of Revenue: 3409039000.00
GUFICBIO.NS income_statement (annual, 2023-03-31) — Reconciled Depreciation: 222811000.00
GUFICBIO.NS income_statement (annual, 2023-03-31) — Rent And Landing Fees: 13368000.00
GUFICBIO.NS income_statement (annual, 2023-03-31) — Rent Expense Supplemental: 13368000.00
GUFICBIO.NS income_statement (annual, 2023-03-31) — Research And Development: 51559000.00
GUFICBIO.NS balance_sheet (annual, 2023-03-31) — Restricted Cash: 180848000.00
GUFICBIO.NS balance_sheet (annual, 2023-03-31) — Retained Earnings: 2672903000.00
GUFICBIO.NS cash_flow (annual, 2023-03-31) — Sale Of PPE: 316000.00
GUFICBIO.NS income_statement (annual, 2023-03-31) — Selling And Marketing Expense: 59562000.00
GUFICBIO.NS income_statement (annual, 2023-03-31) — Selling General And Administration: 208569000.00
GUFICBIO.NS balance_sheet (annual, 2023-03-31) — Share Issued: 96944506.00
GUFICBIO.NS cash_flow (annual, 2023-03-31) — Short Term Debt Issuance: 1426288000.00
GUFICBIO.NS income_statement (annual, 2023-03-31) — Special Income Charges: 302000.00
GUFICBIO.NS balance_sheet (annual, 2023-03-31) — Stockholders Equity: 3478082000.00
GUFICBIO.NS balance_sheet (annual, 2023-03-31) — Tangible Book Value: 3471294000.00
GUFICBIO.NS income_statement (annual, 2023-03-31) — Tax Effect Of Unusual Items: 76450.46
GUFICBIO.NS income_statement (annual, 2023-03-31) — Tax Provision: 270161000.00
GUFICBIO.NS income_statement (annual, 2023-03-31) — Tax Rate For Calcs: 0.25
GUFICBIO.NS balance_sheet (annual, 2023-03-31) — Taxes Receivable: 0.00
GUFICBIO.NS cash_flow (annual, 2023-03-31) — Taxes Refund Paid: -276962000.00
GUFICBIO.NS balance_sheet (annual, 2023-03-31) — Total Assets: 8611595000.00
GUFICBIO.NS balance_sheet (annual, 2023-03-31) — Total Capitalization: 5384875000.00
GUFICBIO.NS balance_sheet (annual, 2023-03-31) — Total Debt: 3341928000.00
GUFICBIO.NS balance_sheet (annual, 2023-03-31) — Total Equity Gross Minority Interest: 3478082000.00
GUFICBIO.NS income_statement (annual, 2023-03-31) — Total Expenses: 5644237000.00
GUFICBIO.NS balance_sheet (annual, 2023-03-31) — Total Liabilities Net Minority Interest: 5133513000.00
GUFICBIO.NS balance_sheet (annual, 2023-03-31) — Total Non Current Assets: 3970509000.00
GUFICBIO.NS balance_sheet (annual, 2023-03-31) — Total Non Current Liabilities Net Minority Interest: 2251438000.00
GUFICBIO.NS income_statement (annual, 2023-03-31) — Total Other Finance Cost: 15876000.00
GUFICBIO.NS balance_sheet (annual, 2023-03-31) — Total Tax Payable: 31241000.00
GUFICBIO.NS income_statement (annual, 2023-03-31) — Total Unusual Items: 302000.00
GUFICBIO.NS income_statement (annual, 2023-03-31) — Total Unusual Items Excluding Goodwill: 302000.00
GUFICBIO.NS balance_sheet (annual, 2023-03-31) — Work In Process: 573856000.00
GUFICBIO.NS balance_sheet (annual, 2023-03-31) — Working Capital: 1759011000.00
GUFICBIO.NS income_statement (annual, 2024-03-31) — +Operating Expense: 2377809000.00
GUFICBIO.NS income_statement (annual, 2024-03-31) — +Total Revenue: 7696562000.00
GUFICBIO.NS balance_sheet (annual, 2024-03-31) — Accounts Payable: 1662687000.00
GUFICBIO.NS balance_sheet (annual, 2024-03-31) — Accounts Receivable: 3299353000.00
GUFICBIO.NS balance_sheet (annual, 2024-03-31) — Accumulated Depreciation: -862103000.00
GUFICBIO.NS balance_sheet (annual, 2024-03-31) — Additional Paid In Capital: 996567000.00
GUFICBIO.NS balance_sheet (annual, 2024-03-31) — Allowance For Doubtful Accounts Receivable: -55859000.00
GUFICBIO.NS balance_sheet (annual, 2024-03-31) — Available For Sale Securities: 7843000.00
GUFICBIO.NS income_statement (annual, 2024-03-31) — Basic Average Shares: 98519940.00
GUFICBIO.NS income_statement (annual, 2024-03-31) — Basic EPS: 8.74
GUFICBIO.NS cash_flow (annual, 2024-03-31) — Beginning Cash Position: 286019000.00
GUFICBIO.NS balance_sheet (annual, 2024-03-31) — Buildings And Improvements: 779448000.00
GUFICBIO.NS cash_flow (annual, 2024-03-31) — Capital Expenditure: -1126945000.00
GUFICBIO.NS balance_sheet (annual, 2024-03-31) — Capital Lease Obligations: 158812000.00
GUFICBIO.NS balance_sheet (annual, 2024-03-31) — Capital Stock: 100278000.00
GUFICBIO.NS balance_sheet (annual, 2024-03-31) — Cash And Cash Equivalents: 11368000.00
GUFICBIO.NS balance_sheet (annual, 2024-03-31) — Cash Cash Equivalents And Short Term Investments: 11368000.00
GUFICBIO.NS cash_flow (annual, 2024-03-31) — Cash Dividends Paid: -9720000.00
GUFICBIO.NS balance_sheet (annual, 2024-03-31) — Cash Financial: 11368000.00
GUFICBIO.NS cash_flow (annual, 2024-03-31) — Change In Inventory: -170246000.00
GUFICBIO.NS cash_flow (annual, 2024-03-31) — Change In Payable: 400358000.00
GUFICBIO.NS cash_flow (annual, 2024-03-31) — Change In Receivables: -1532419000.00
GUFICBIO.NS cash_flow (annual, 2024-03-31) — Change In Working Capital: -1302307000.00
GUFICBIO.NS cash_flow (annual, 2024-03-31) — Changes In Cash: -274650000.00
GUFICBIO.NS balance_sheet (annual, 2024-03-31) — Common Stock: 100278000.00
GUFICBIO.NS balance_sheet (annual, 2024-03-31) — Common Stock Equity: 5325605000.00
GUFICBIO.NS cash_flow (annual, 2024-03-31) — Common Stock Issuance: 999900000.00
GUFICBIO.NS balance_sheet (annual, 2024-03-31) — Construction In Progress: 3208911000.00
GUFICBIO.NS income_statement (annual, 2024-03-31) — Cost Of Revenue: 3992924000.00
GUFICBIO.NS balance_sheet (annual, 2024-03-31) — Current Assets: 6004792000.00
GUFICBIO.NS balance_sheet (annual, 2024-03-31) — Current Capital Lease Obligation: 43261000.00
GUFICBIO.NS balance_sheet (annual, 2024-03-31) — Current Debt: 1630714000.00
GUFICBIO.NS balance_sheet (annual, 2024-03-31) — Current Debt And Capital Lease Obligation: 1673975000.00
GUFICBIO.NS balance_sheet (annual, 2024-03-31) — Current Deferred Taxes Liabilities: 25453000.00
GUFICBIO.NS balance_sheet (annual, 2024-03-31) — Current Liabilities: 3720489000.00
GUFICBIO.NS balance_sheet (annual, 2024-03-31) — Current Provisions: 47363000.00
GUFICBIO.NS cash_flow (annual, 2024-03-31) — Deferred Tax: 295359000.00
GUFICBIO.NS cash_flow (annual, 2024-03-31) — Depreciation: 170172000.00
GUFICBIO.NS cash_flow (annual, 2024-03-31) — Depreciation And Amortization: 170172000.00
GUFICBIO.NS income_statement (annual, 2024-03-31) — Depreciation And Amortization In Income Statement: 170172000.00
GUFICBIO.NS income_statement (annual, 2024-03-31) — Depreciation Income Statement: 170172000.00
GUFICBIO.NS income_statement (annual, 2024-03-31) — Diluted Average Shares: 98519940.00
GUFICBIO.NS income_statement (annual, 2024-03-31) — Diluted EPS: 8.74
GUFICBIO.NS income_statement (annual, 2024-03-31) — Diluted NI Availto Com Stockholders: 861356000.00
GUFICBIO.NS balance_sheet (annual, 2024-03-31) — Dividends Payable: 199000.00
GUFICBIO.NS cash_flow (annual, 2024-03-31) — Dividends Received Cfi: 29000.00
GUFICBIO.NS income_statement (annual, 2024-03-31) — EBIT: 1304296000.00
GUFICBIO.NS income_statement (annual, 2024-03-31) — EBITDA: 1474468000.00
GUFICBIO.NS cash_flow (annual, 2024-03-31) — End Cash Position: 11368000.00
GUFICBIO.NS balance_sheet (annual, 2024-03-31) — Financial Assets Designatedas Fair Value Through Profitor Loss Total: 10000000.00
GUFICBIO.NS cash_flow (annual, 2024-03-31) — Financing Cash Flow: 823810000.00
GUFICBIO.NS balance_sheet (annual, 2024-03-31) — Finished Goods: 483781000.00
GUFICBIO.NS cash_flow (annual, 2024-03-31) — Free Cash Flow: -1201516000.00
GUFICBIO.NS cash_flow (annual, 2024-03-31) — Gain Loss On Investment Securities: -4000.00
GUFICBIO.NS cash_flow (annual, 2024-03-31) — Gain Loss On Sale Of PPE: 22995000.00
GUFICBIO.NS income_statement (annual, 2024-03-31) — General And Administrative Expense: 185916000.00
GUFICBIO.NS balance_sheet (annual, 2024-03-31) — Goodwill And Other Intangible Assets: 56193000.00
GUFICBIO.NS balance_sheet (annual, 2024-03-31) — Gross Accounts Receivable: 3355212000.00
GUFICBIO.NS balance_sheet (annual, 2024-03-31) — Gross PPE: 5603754000.00
GUFICBIO.NS income_statement (annual, 2024-03-31) — Gross Profit: 3703638000.00
GUFICBIO.NS balance_sheet (annual, 2024-03-31) — Held To Maturity Securities: 10000000.00
GUFICBIO.NS income_statement (annual, 2024-03-31) — Interest Expense: 147581000.00
GUFICBIO.NS income_statement (annual, 2024-03-31) — Interest Expense Non Operating: 147581000.00
GUFICBIO.NS income_statement (annual, 2024-03-31) — Interest Income: 14121000.00
GUFICBIO.NS income_statement (annual, 2024-03-31) — Interest Income Non Operating: 14121000.00
GUFICBIO.NS cash_flow (annual, 2024-03-31) — Interest Paid Cff: -126589000.00
GUFICBIO.NS cash_flow (annual, 2024-03-31) — Interest Received Cfi: 10014000.00
GUFICBIO.NS balance_sheet (annual, 2024-03-31) — Inventory: 2004821000.00
GUFICBIO.NS balance_sheet (annual, 2024-03-31) — Invested Capital: 8495950000.00
GUFICBIO.NS cash_flow (annual, 2024-03-31) — Investing Cash Flow: -1023889000.00
GUFICBIO.NS balance_sheet (annual, 2024-03-31) — Investmentin Financial Assets: 17843000.00
GUFICBIO.NS cash_flow (annual, 2024-03-31) — Issuance Of Capital Stock: 999900000.00
GUFICBIO.NS cash_flow (annual, 2024-03-31) — Issuance Of Debt: 423436000.00
GUFICBIO.NS balance_sheet (annual, 2024-03-31) — Land And Improvements: 98900000.00
GUFICBIO.NS balance_sheet (annual, 2024-03-31) — Long Term Capital Lease Obligation: 115551000.00
GUFICBIO.NS balance_sheet (annual, 2024-03-31) — Long Term Debt: 1539631000.00
GUFICBIO.NS balance_sheet (annual, 2024-03-31) — Long Term Debt And Capital Lease Obligation: 1655182000.00
GUFICBIO.NS cash_flow (annual, 2024-03-31) — Long Term Debt Payments: -368366000.00
GUFICBIO.NS balance_sheet (annual, 2024-03-31) — Long Term Provisions: 153770000.00
GUFICBIO.NS balance_sheet (annual, 2024-03-31) — Machinery Furniture Equipment: 1461884000.00
GUFICBIO.NS balance_sheet (annual, 2024-03-31) — Minority Interest: 0.00
GUFICBIO.NS income_statement (annual, 2024-03-31) — Minority Interests: 0.00
GUFICBIO.NS cash_flow (annual, 2024-03-31) — Net Business Purchase And Sale: 0.00
GUFICBIO.NS cash_flow (annual, 2024-03-31) — Net Common Stock Issuance: 999900000.00
GUFICBIO.NS balance_sheet (annual, 2024-03-31) — Net Debt: 3158977000.00
GUFICBIO.NS income_statement (annual, 2024-03-31) — Net Income: 861356000.00
GUFICBIO.NS income_statement (annual, 2024-03-31) — Net Income Common Stockholders: 861356000.00
GUFICBIO.NS income_statement (annual, 2024-03-31) — Net Income Continuous Operations: 861356000.00
GUFICBIO.NS income_statement (annual, 2024-03-31) — Net Income From Continuing And Discontinued Operation: 861356000.00
GUFICBIO.NS income_statement (annual, 2024-03-31) — Net Income From Continuing Operation Net Minority Interest: 861356000.00
GUFICBIO.NS cash_flow (annual, 2024-03-31) — Net Income From Continuing Operations: 861356000.00
GUFICBIO.NS income_statement (annual, 2024-03-31) — Net Income Including Noncontrolling Interests: 861356000.00
GUFICBIO.NS income_statement (annual, 2024-03-31) — Net Interest Income: -153770000.00
GUFICBIO.NS cash_flow (annual, 2024-03-31) — Net Investment Purchase And Sale: -10000000.00
GUFICBIO.NS cash_flow (annual, 2024-03-31) — Net Issuance Payments Of Debt: 55070000.00
GUFICBIO.NS cash_flow (annual, 2024-03-31) — Net Long Term Debt Issuance: -368366000.00
GUFICBIO.NS income_statement (annual, 2024-03-31) — Net Non Operating Interest Income Expense: -153770000.00
GUFICBIO.NS cash_flow (annual, 2024-03-31) — Net Other Financing Charges: -5600000.00
GUFICBIO.NS cash_flow (annual, 2024-03-31) — Net Other Investing Changes: 57351000.00
GUFICBIO.NS balance_sheet (annual, 2024-03-31) — Net PPE: 4741651000.00
GUFICBIO.NS cash_flow (annual, 2024-03-31) — Net PPE Purchase And Sale: -1081283000.00
GUFICBIO.NS cash_flow (annual, 2024-03-31) — Net Short Term Debt Issuance: 423436000.00
GUFICBIO.NS balance_sheet (annual, 2024-03-31) — Net Tangible Assets: 5269412000.00
GUFICBIO.NS balance_sheet (annual, 2024-03-31) — Non Current Deferred Revenue: 49736000.00
GUFICBIO.NS balance_sheet (annual, 2024-03-31) — Non Current Deferred Taxes Assets: 0.00
GUFICBIO.NS balance_sheet (annual, 2024-03-31) — Non Current Deferred Taxes Liabilities: 20632000.00
GUFICBIO.NS balance_sheet (annual, 2024-03-31) — Non Current Prepaid Assets: 100790000.00
GUFICBIO.NS income_statement (annual, 2024-03-31) — Normalized EBITDA: 1497463000.00
GUFICBIO.NS income_statement (annual, 2024-03-31) — Normalized Income: 878480376.50
GUFICBIO.NS cash_flow (annual, 2024-03-31) — Operating Cash Flow: -74571000.00
GUFICBIO.NS income_statement (annual, 2024-03-31) — Operating Income: 1325829000.00
GUFICBIO.NS income_statement (annual, 2024-03-31) — Operating Revenue: 7696562000.00
GUFICBIO.NS balance_sheet (annual, 2024-03-31) — Ordinary Shares Number: 100277506.00
GUFICBIO.NS cash_flow (annual, 2024-03-31) — Other Cash Adjustment Outside Changein Cash: -1000.00
GUFICBIO.NS balance_sheet (annual, 2024-03-31) — Other Current Assets: 28913000.00
GUFICBIO.NS balance_sheet (annual, 2024-03-31) — Other Current Liabilities: 173600000.00
GUFICBIO.NS balance_sheet (annual, 2024-03-31) — Other Equity Interest: 5225328000.00
GUFICBIO.NS balance_sheet (annual, 2024-03-31) — Other Intangible Assets: 56193000.00
GUFICBIO.NS cash_flow (annual, 2024-03-31) — Other Non Cash Items: 148294000.00
GUFICBIO.NS balance_sheet (annual, 2024-03-31) — Other Non Current Assets: 1000.00
GUFICBIO.NS income_statement (annual, 2024-03-31) — Other Non Operating Income Expenses: 2681000.00
GUFICBIO.NS income_statement (annual, 2024-03-31) — Other Operating Expenses: 1101789000.00
GUFICBIO.NS balance_sheet (annual, 2024-03-31) — Other Payable: 272360000.00
GUFICBIO.NS balance_sheet (annual, 2024-03-31) — Other Properties: 54611000.00
GUFICBIO.NS balance_sheet (annual, 2024-03-31) — Other Receivables: 3733000.00
GUFICBIO.NS balance_sheet (annual, 2024-03-31) — Other Short Term Investments: 123472000.00
GUFICBIO.NS income_statement (annual, 2024-03-31) — Other Special Charges: 22995000.00
GUFICBIO.NS income_statement (annual, 2024-03-31) — Otherunder Preferred Stock Dividend: 0.00
GUFICBIO.NS balance_sheet (annual, 2024-03-31) — Payables: 1935246000.00
GUFICBIO.NS balance_sheet (annual, 2024-03-31) — Prepaid Assets: 533132000.00
GUFICBIO.NS income_statement (annual, 2024-03-31) — Pretax Income: 1156715000.00
GUFICBIO.NS balance_sheet (annual, 2024-03-31) — Properties: 0.00
GUFICBIO.NS cash_flow (annual, 2024-03-31) — Purchase Of Business: -10000000.00
GUFICBIO.NS cash_flow (annual, 2024-03-31) — Purchase Of Investment: -10000000.00
GUFICBIO.NS cash_flow (annual, 2024-03-31) — Purchase Of PPE: -1126945000.00
GUFICBIO.NS balance_sheet (annual, 2024-03-31) — Raw Materials: 968277000.00
GUFICBIO.NS income_statement (annual, 2024-03-31) — Reconciled Cost Of Revenue: 3992924000.00
GUFICBIO.NS income_statement (annual, 2024-03-31) — Reconciled Depreciation: 170172000.00
GUFICBIO.NS income_statement (annual, 2024-03-31) — Rent And Landing Fees: 14700000.00
GUFICBIO.NS income_statement (annual, 2024-03-31) — Rent Expense Supplemental: 14700000.00
GUFICBIO.NS cash_flow (annual, 2024-03-31) — Repayment Of Debt: -368366000.00
GUFICBIO.NS income_statement (annual, 2024-03-31) — Research And Development: 54125000.00
GUFICBIO.NS balance_sheet (annual, 2024-03-31) — Restricted Cash: 123472000.00
GUFICBIO.NS balance_sheet (annual, 2024-03-31) — Retained Earnings: 3524565000.00
GUFICBIO.NS cash_flow (annual, 2024-03-31) — Sale Of Business: 0.00
GUFICBIO.NS cash_flow (annual, 2024-03-31) — Sale Of PPE: 45662000.00
GUFICBIO.NS income_statement (annual, 2024-03-31) — Selling And Marketing Expense: 21225000.00
GUFICBIO.NS income_statement (annual, 2024-03-31) — Selling General And Administration: 207141000.00
GUFICBIO.NS balance_sheet (annual, 2024-03-31) — Share Issued: 100277506.00
GUFICBIO.NS cash_flow (annual, 2024-03-31) — Short Term Debt Issuance: 423436000.00
GUFICBIO.NS income_statement (annual, 2024-03-31) — Special Income Charges: -22995000.00
GUFICBIO.NS balance_sheet (annual, 2024-03-31) — Stockholders Equity: 5325605000.00
GUFICBIO.NS balance_sheet (annual, 2024-03-31) — Tangible Book Value: 5269412000.00
GUFICBIO.NS income_statement (annual, 2024-03-31) — Tax Effect Of Unusual Items: -5870623.50
GUFICBIO.NS income_statement (annual, 2024-03-31) — Tax Provision: 295359000.00
GUFICBIO.NS income_statement (annual, 2024-03-31) — Tax Rate For Calcs: 0.26
GUFICBIO.NS balance_sheet (annual, 2024-03-31) — Taxes Receivable: 0.00
GUFICBIO.NS cash_flow (annual, 2024-03-31) — Taxes Refund Paid: -270436000.00
GUFICBIO.NS balance_sheet (annual, 2024-03-31) — Total Assets: 10925414000.00
GUFICBIO.NS balance_sheet (annual, 2024-03-31) — Total Capitalization: 6865236000.00
GUFICBIO.NS balance_sheet (annual, 2024-03-31) — Total Debt: 3329157000.00
GUFICBIO.NS balance_sheet (annual, 2024-03-31) — Total Equity Gross Minority Interest: 5325605000.00
GUFICBIO.NS income_statement (annual, 2024-03-31) — Total Expenses: 6370733000.00
GUFICBIO.NS balance_sheet (annual, 2024-03-31) — Total Liabilities Net Minority Interest: 5599809000.00
GUFICBIO.NS balance_sheet (annual, 2024-03-31) — Total Non Current Assets: 4920622000.00
GUFICBIO.NS balance_sheet (annual, 2024-03-31) — Total Non Current Liabilities Net Minority Interest: 1879320000.00
GUFICBIO.NS income_statement (annual, 2024-03-31) — Total Other Finance Cost: 20310000.00
GUFICBIO.NS balance_sheet (annual, 2024-03-31) — Total Tax Payable: 25453000.00
GUFICBIO.NS income_statement (annual, 2024-03-31) — Total Unusual Items: -22995000.00
GUFICBIO.NS income_statement (annual, 2024-03-31) — Total Unusual Items Excluding Goodwill: -22995000.00
GUFICBIO.NS balance_sheet (annual, 2024-03-31) — Work In Process: 552763000.00
GUFICBIO.NS balance_sheet (annual, 2024-03-31) — Working Capital: 2284303000.00
GUFICBIO.NS balance_sheet (quarterly, 2024-09-30) — Accounts Payable: 1685984000.00
GUFICBIO.NS balance_sheet (quarterly, 2024-09-30) — Accounts Receivable: 3108394000.00
GUFICBIO.NS balance_sheet (quarterly, 2024-09-30) — Available For Sale Securities: 116976000.00
GUFICBIO.NS income_statement (quarterly, 2024-09-30) — Basic Average Shares: 100316129.00
GUFICBIO.NS income_statement (quarterly, 2024-09-30) — Basic EPS: 2.17
GUFICBIO.NS balance_sheet (quarterly, 2024-09-30) — Capital Lease Obligations: 123415000.00
GUFICBIO.NS balance_sheet (quarterly, 2024-09-30) — Capital Stock: 100278000.00
GUFICBIO.NS balance_sheet (quarterly, 2024-09-30) — Cash And Cash Equivalents: 57370000.00
GUFICBIO.NS balance_sheet (quarterly, 2024-09-30) — Cash Cash Equivalents And Short Term Investments: 193955000.00
GUFICBIO.NS balance_sheet (quarterly, 2024-09-30) — Common Stock: 100278000.00
GUFICBIO.NS balance_sheet (quarterly, 2024-09-30) — Common Stock Equity: 5741789000.00
GUFICBIO.NS balance_sheet (quarterly, 2024-09-30) — Construction In Progress: 3631914000.00
GUFICBIO.NS balance_sheet (quarterly, 2024-09-30) — Current Assets: 5783877000.00
GUFICBIO.NS balance_sheet (quarterly, 2024-09-30) — Current Capital Lease Obligation: 26048000.00
GUFICBIO.NS balance_sheet (quarterly, 2024-09-30) — Current Debt: 1407981000.00
GUFICBIO.NS balance_sheet (quarterly, 2024-09-30) — Current Debt And Capital Lease Obligation: 1434029000.00
GUFICBIO.NS balance_sheet (quarterly, 2024-09-30) — Current Liabilities: 3542450000.00
GUFICBIO.NS balance_sheet (quarterly, 2024-09-30) — Current Provisions: 48832000.00
GUFICBIO.NS income_statement (quarterly, 2024-09-30) — Diluted Average Shares: 100316129.00
GUFICBIO.NS income_statement (quarterly, 2024-09-30) — Diluted EPS: 2.17
GUFICBIO.NS balance_sheet (quarterly, 2024-09-30) — Goodwill And Other Intangible Assets: 63495000.00
GUFICBIO.NS balance_sheet (quarterly, 2024-09-30) — Gross PPE: 5061226000.00
GUFICBIO.NS balance_sheet (quarterly, 2024-09-30) — Inventory: 1868366000.00
GUFICBIO.NS balance_sheet (quarterly, 2024-09-30) — Invested Capital: 8577745000.00
GUFICBIO.NS balance_sheet (quarterly, 2024-09-30) — Investmentin Financial Assets: 116976000.00
GUFICBIO.NS balance_sheet (quarterly, 2024-09-30) — Long Term Capital Lease Obligation: 97367000.00
GUFICBIO.NS balance_sheet (quarterly, 2024-09-30) — Long Term Debt: 1427975000.00
GUFICBIO.NS balance_sheet (quarterly, 2024-09-30) — Long Term Debt And Capital Lease Obligation: 1525342000.00
GUFICBIO.NS balance_sheet (quarterly, 2024-09-30) — Long Term Provisions: 165001000.00
GUFICBIO.NS balance_sheet (quarterly, 2024-09-30) — Minority Interest: 12000.00
GUFICBIO.NS income_statement (quarterly, 2024-09-30) — Minority Interests: -6000.00
GUFICBIO.NS balance_sheet (quarterly, 2024-09-30) — Net Debt: 2778586000.00
GUFICBIO.NS balance_sheet (quarterly, 2024-09-30) — Net PPE: 5061226000.00
GUFICBIO.NS balance_sheet (quarterly, 2024-09-30) — Net Tangible Assets: 5678294000.00
GUFICBIO.NS balance_sheet (quarterly, 2024-09-30) — Non Current Deferred Taxes Assets: 2000.00
GUFICBIO.NS balance_sheet (quarterly, 2024-09-30) — Non Current Deferred Taxes Liabilities: 22974000.00
GUFICBIO.NS balance_sheet (quarterly, 2024-09-30) — Ordinary Shares Number: 100277506.00
GUFICBIO.NS balance_sheet (quarterly, 2024-09-30) — Other Current Assets: 609645000.00
GUFICBIO.NS balance_sheet (quarterly, 2024-09-30) — Other Current Liabilities: 206595000.00
GUFICBIO.NS balance_sheet (quarterly, 2024-09-30) — Other Equity Interest: 5641511000.00
GUFICBIO.NS balance_sheet (quarterly, 2024-09-30) — Other Non Current Assets: 18575000.00
GUFICBIO.NS balance_sheet (quarterly, 2024-09-30) — Other Properties: 1429312000.00
GUFICBIO.NS balance_sheet (quarterly, 2024-09-30) — Other Receivables: 3517000.00
GUFICBIO.NS balance_sheet (quarterly, 2024-09-30) — Other Short Term Investments: 136585000.00
GUFICBIO.NS balance_sheet (quarterly, 2024-09-30) — Payables: 1755328000.00
GUFICBIO.NS balance_sheet (quarterly, 2024-09-30) — Share Issued: 100277506.00
GUFICBIO.NS balance_sheet (quarterly, 2024-09-30) — Stockholders Equity: 5741789000.00
GUFICBIO.NS balance_sheet (quarterly, 2024-09-30) — Tangible Book Value: 5678294000.00
GUFICBIO.NS balance_sheet (quarterly, 2024-09-30) — Total Assets: 11046704000.00
GUFICBIO.NS balance_sheet (quarterly, 2024-09-30) — Total Capitalization: 7169764000.00
GUFICBIO.NS balance_sheet (quarterly, 2024-09-30) — Total Debt: 2959371000.00
GUFICBIO.NS balance_sheet (quarterly, 2024-09-30) — Total Equity Gross Minority Interest: 5741801000.00
GUFICBIO.NS balance_sheet (quarterly, 2024-09-30) — Total Liabilities Net Minority Interest: 5304903000.00
GUFICBIO.NS balance_sheet (quarterly, 2024-09-30) — Total Non Current Assets: 5262827000.00
GUFICBIO.NS balance_sheet (quarterly, 2024-09-30) — Total Non Current Liabilities Net Minority Interest: 1762453000.00
GUFICBIO.NS balance_sheet (quarterly, 2024-09-30) — Total Tax Payable: 69344000.00
GUFICBIO.NS balance_sheet (quarterly, 2024-09-30) — Working Capital: 2241427000.00
GUFICBIO.NS income_statement (quarterly, 2024-12-31) — +Operating Expense: 843223000.00
GUFICBIO.NS income_statement (quarterly, 2024-12-31) — +Total Revenue: 2077939000.00
GUFICBIO.NS income_statement (quarterly, 2024-12-31) — Basic Average Shares: 100026943.00
GUFICBIO.NS income_statement (quarterly, 2024-12-31) — Basic EPS: 1.93
GUFICBIO.NS income_statement (quarterly, 2024-12-31) — Cost Of Revenue: 941656000.00
GUFICBIO.NS income_statement (quarterly, 2024-12-31) — Depreciation And Amortization In Income Statement: 46182000.00
GUFICBIO.NS income_statement (quarterly, 2024-12-31) — Depreciation Income Statement: 46182000.00
GUFICBIO.NS income_statement (quarterly, 2024-12-31) — Diluted Average Shares: 100026943.00
GUFICBIO.NS income_statement (quarterly, 2024-12-31) — Diluted EPS: 1.93
GUFICBIO.NS income_statement (quarterly, 2024-12-31) — Diluted NI Availto Com Stockholders: 193052000.00
GUFICBIO.NS income_statement (quarterly, 2024-12-31) — EBIT: 311696000.00
GUFICBIO.NS income_statement (quarterly, 2024-12-31) — EBITDA: 357878000.00
GUFICBIO.NS income_statement (quarterly, 2024-12-31) — Gross Profit: 1136283000.00
GUFICBIO.NS income_statement (quarterly, 2024-12-31) — Interest Expense: 49091000.00
GUFICBIO.NS income_statement (quarterly, 2024-12-31) — Interest Expense Non Operating: 49091000.00
GUFICBIO.NS income_statement (quarterly, 2024-12-31) — Minority Interests: 1000.00
GUFICBIO.NS income_statement (quarterly, 2024-12-31) — Net Income: 193052000.00
GUFICBIO.NS income_statement (quarterly, 2024-12-31) — Net Income Common Stockholders: 193052000.00
GUFICBIO.NS income_statement (quarterly, 2024-12-31) — Net Income Continuous Operations: 193051000.00
GUFICBIO.NS income_statement (quarterly, 2024-12-31) — Net Income From Continuing And Discontinued Operation: 193052000.00
GUFICBIO.NS income_statement (quarterly, 2024-12-31) — Net Income From Continuing Operation Net Minority Interest: 193052000.00
GUFICBIO.NS income_statement (quarterly, 2024-12-31) — Net Income Including Noncontrolling Interests: 193051000.00
GUFICBIO.NS income_statement (quarterly, 2024-12-31) — Net Interest Income: -49091000.00
GUFICBIO.NS income_statement (quarterly, 2024-12-31) — Net Non Operating Interest Income Expense: -49091000.00
GUFICBIO.NS income_statement (quarterly, 2024-12-31) — Normalized EBITDA: 357878000.00
GUFICBIO.NS income_statement (quarterly, 2024-12-31) — Normalized Income: 193052000.00
GUFICBIO.NS income_statement (quarterly, 2024-12-31) — Operating Income: 293060000.00
GUFICBIO.NS income_statement (quarterly, 2024-12-31) — Operating Revenue: 2077939000.00
GUFICBIO.NS income_statement (quarterly, 2024-12-31) — Other Non Operating Income Expenses: 18636000.00
GUFICBIO.NS income_statement (quarterly, 2024-12-31) — Other Operating Expenses: 457464000.00
GUFICBIO.NS income_statement (quarterly, 2024-12-31) — Otherunder Preferred Stock Dividend: 0.00
GUFICBIO.NS income_statement (quarterly, 2024-12-31) — Pretax Income: 262605000.00
GUFICBIO.NS income_statement (quarterly, 2024-12-31) — Reconciled Cost Of Revenue: 941656000.00
GUFICBIO.NS income_statement (quarterly, 2024-12-31) — Reconciled Depreciation: 46182000.00
GUFICBIO.NS income_statement (quarterly, 2024-12-31) — Special Income Charges: 0.00
GUFICBIO.NS income_statement (quarterly, 2024-12-31) — Tax Effect Of Unusual Items: 0.00
GUFICBIO.NS income_statement (quarterly, 2024-12-31) — Tax Provision: 69554000.00
GUFICBIO.NS income_statement (quarterly, 2024-12-31) — Tax Rate For Calcs: 0.26
GUFICBIO.NS income_statement (quarterly, 2024-12-31) — Total Expenses: 1784879000.00
GUFICBIO.NS income_statement (quarterly, 2024-12-31) — Total Unusual Items: 0.00
GUFICBIO.NS income_statement (quarterly, 2024-12-31) — Total Unusual Items Excluding Goodwill: 0.00
GUFICBIO.NS income_statement (annual, 2025-03-31) — +Operating Expense: 3314764000.00
GUFICBIO.NS income_statement (quarterly, 2025-03-31) — +Operating Expense: 968224000.00
GUFICBIO.NS income_statement (annual, 2025-03-31) — +Total Revenue: 8198059000.00
GUFICBIO.NS income_statement (quarterly, 2025-03-31) — +Total Revenue: 2050201000.00
GUFICBIO.NS balance_sheet (annual, 2025-03-31) — Accounts Payable: 1587495000.00
GUFICBIO.NS balance_sheet (quarterly, 2025-03-31) — Accounts Payable: 1587495000.00
GUFICBIO.NS balance_sheet (annual, 2025-03-31) — Accounts Receivable: 3146069000.00
GUFICBIO.NS balance_sheet (quarterly, 2025-03-31) — Accounts Receivable: 3146069000.00
GUFICBIO.NS balance_sheet (annual, 2025-03-31) — Accumulated Depreciation: -1064146000.00
GUFICBIO.NS balance_sheet (quarterly, 2025-03-31) — Accumulated Depreciation: -1064146000.00
GUFICBIO.NS balance_sheet (annual, 2025-03-31) — Additional Paid In Capital: 996567000.00
GUFICBIO.NS balance_sheet (quarterly, 2025-03-31) — Additional Paid In Capital: 996567000.00
GUFICBIO.NS balance_sheet (annual, 2025-03-31) — Allowance For Doubtful Accounts Receivable: -71161000.00
GUFICBIO.NS balance_sheet (quarterly, 2025-03-31) — Allowance For Doubtful Accounts Receivable: -71161000.00
GUFICBIO.NS balance_sheet (annual, 2025-03-31) — Available For Sale Securities: 7843000.00
GUFICBIO.NS balance_sheet (quarterly, 2025-03-31) — Available For Sale Securities: 7843000.00
GUFICBIO.NS income_statement (annual, 2025-03-31) — Basic Average Shares: 100215108.00
GUFICBIO.NS income_statement (quarterly, 2025-03-31) — Basic Average Shares: 100253247.00
GUFICBIO.NS income_statement (annual, 2025-03-31) — Basic EPS: 6.95
GUFICBIO.NS income_statement (quarterly, 2025-03-31) — Basic EPS: 0.77
GUFICBIO.NS cash_flow (annual, 2025-03-31) — Beginning Cash Position: 11368000.00
GUFICBIO.NS balance_sheet (annual, 2025-03-31) — Buildings And Improvements: 1789510000.00
GUFICBIO.NS balance_sheet (quarterly, 2025-03-31) — Buildings And Improvements: 1789510000.00
GUFICBIO.NS cash_flow (annual, 2025-03-31) — Capital Expenditure: -755255000.00
GUFICBIO.NS balance_sheet (annual, 2025-03-31) — Capital Lease Obligations: 258200000.00
GUFICBIO.NS balance_sheet (quarterly, 2025-03-31) — Capital Lease Obligations: 258200000.00
GUFICBIO.NS balance_sheet (annual, 2025-03-31) — Capital Stock: 100278000.00
GUFICBIO.NS balance_sheet (quarterly, 2025-03-31) — Capital Stock: 100278000.00
GUFICBIO.NS balance_sheet (annual, 2025-03-31) — Cash And Cash Equivalents: 157233000.00
GUFICBIO.NS balance_sheet (quarterly, 2025-03-31) — Cash And Cash Equivalents: 157233000.00
GUFICBIO.NS balance_sheet (annual, 2025-03-31) — Cash Cash Equivalents And Short Term Investments: 157233000.00
GUFICBIO.NS balance_sheet (quarterly, 2025-03-31) — Cash Cash Equivalents And Short Term Investments: 157233000.00
GUFICBIO.NS cash_flow (annual, 2025-03-31) — Cash Dividends Paid: -10028000.00
GUFICBIO.NS balance_sheet (annual, 2025-03-31) — Cash Financial: 157233000.00
GUFICBIO.NS balance_sheet (quarterly, 2025-03-31) — Cash Financial: 157233000.00
GUFICBIO.NS cash_flow (annual, 2025-03-31) — Change In Inventory: -163869000.00
GUFICBIO.NS cash_flow (annual, 2025-03-31) — Change In Payable: 165795000.00
GUFICBIO.NS cash_flow (annual, 2025-03-31) — Change In Receivables: 73548000.00
GUFICBIO.NS cash_flow (annual, 2025-03-31) — Change In Working Capital: 75473000.00
GUFICBIO.NS cash_flow (annual, 2025-03-31) — Changes In Cash: 145866000.00
GUFICBIO.NS balance_sheet (annual, 2025-03-31) — Common Stock: 100278000.00
GUFICBIO.NS balance_sheet (quarterly, 2025-03-31) — Common Stock: 100278000.00
GUFICBIO.NS balance_sheet (annual, 2025-03-31) — Common Stock Equity: 6010768000.00
GUFICBIO.NS balance_sheet (quarterly, 2025-03-31) — Common Stock Equity: 6010768000.00
GUFICBIO.NS cash_flow (annual, 2025-03-31) — Common Stock Issuance: 0.00
GUFICBIO.NS balance_sheet (annual, 2025-03-31) — Construction In Progress: 250454000.00
GUFICBIO.NS balance_sheet (quarterly, 2025-03-31) — Construction In Progress: 250454000.00
GUFICBIO.NS income_statement (annual, 2025-03-31) — Cost Of Revenue: 3747011000.00
GUFICBIO.NS income_statement (quarterly, 2025-03-31) — Cost Of Revenue: 896676000.00
GUFICBIO.NS balance_sheet (annual, 2025-03-31) — Current Assets: 6245225000.00
GUFICBIO.NS balance_sheet (quarterly, 2025-03-31) — Current Assets: 6245225000.00
GUFICBIO.NS balance_sheet (annual, 2025-03-31) — Current Capital Lease Obligation: 62267000.00
GUFICBIO.NS balance_sheet (quarterly, 2025-03-31) — Current Capital Lease Obligation: 62267000.00
GUFICBIO.NS balance_sheet (annual, 2025-03-31) — Current Debt: 1798750000.00
GUFICBIO.NS balance_sheet (quarterly, 2025-03-31) — Current Debt: 1798750000.00
GUFICBIO.NS balance_sheet (annual, 2025-03-31) — Current Debt And Capital Lease Obligation: 1861017000.00
GUFICBIO.NS balance_sheet (quarterly, 2025-03-31) — Current Debt And Capital Lease Obligation: 1861017000.00
GUFICBIO.NS balance_sheet (annual, 2025-03-31) — Current Deferred Taxes Liabilities: 0.00
GUFICBIO.NS balance_sheet (quarterly, 2025-03-31) — Current Deferred Taxes Liabilities: 0.00
GUFICBIO.NS balance_sheet (annual, 2025-03-31) — Current Liabilities: 3875572000.00
GUFICBIO.NS balance_sheet (quarterly, 2025-03-31) — Current Liabilities: 3875572000.00
GUFICBIO.NS balance_sheet (annual, 2025-03-31) — Current Provisions: 44029000.00
GUFICBIO.NS balance_sheet (quarterly, 2025-03-31) — Current Provisions: 44029000.00
GUFICBIO.NS cash_flow (annual, 2025-03-31) — Deferred Tax: 244947000.00
GUFICBIO.NS cash_flow (annual, 2025-03-31) — Depreciation: 210646000.00
GUFICBIO.NS cash_flow (annual, 2025-03-31) — Depreciation And Amortization: 210646000.00
GUFICBIO.NS income_statement (annual, 2025-03-31) — Depreciation And Amortization In Income Statement: 210646000.00
GUFICBIO.NS income_statement (quarterly, 2025-03-31) — Depreciation And Amortization In Income Statement: 78434000.00
GUFICBIO.NS income_statement (annual, 2025-03-31) — Depreciation Income Statement: 210646000.00
GUFICBIO.NS income_statement (quarterly, 2025-03-31) — Depreciation Income Statement: 78434000.00
GUFICBIO.NS income_statement (annual, 2025-03-31) — Diluted Average Shares: 100215108.00
GUFICBIO.NS income_statement (quarterly, 2025-03-31) — Diluted Average Shares: 100253247.00
GUFICBIO.NS income_statement (annual, 2025-03-31) — Diluted EPS: 6.95
GUFICBIO.NS income_statement (quarterly, 2025-03-31) — Diluted EPS: 0.77
GUFICBIO.NS income_statement (annual, 2025-03-31) — Diluted NI Availto Com Stockholders: 696495000.00
GUFICBIO.NS income_statement (quarterly, 2025-03-31) — Diluted NI Availto Com Stockholders: 77195000.00
GUFICBIO.NS balance_sheet (annual, 2025-03-31) — Dividends Payable: 184000.00
GUFICBIO.NS balance_sheet (quarterly, 2025-03-31) — Dividends Payable: 184000.00
GUFICBIO.NS cash_flow (annual, 2025-03-31) — Dividends Received Cfi: 0.00
GUFICBIO.NS income_statement (annual, 2025-03-31) — EBIT: 1172550000.00
GUFICBIO.NS income_statement (quarterly, 2025-03-31) — EBIT: 189247000.00
GUFICBIO.NS income_statement (annual, 2025-03-31) — EBITDA: 1383196000.00
GUFICBIO.NS income_statement (quarterly, 2025-03-31) — EBITDA: 267681000.00
GUFICBIO.NS cash_flow (annual, 2025-03-31) — End Cash Position: 157233000.00
GUFICBIO.NS balance_sheet (annual, 2025-03-31) — Financial Assets Designatedas Fair Value Through Profitor Loss Total: 10000000.00
GUFICBIO.NS balance_sheet (quarterly, 2025-03-31) — Financial Assets Designatedas Fair Value Through Profitor Loss Total: 10000000.00
GUFICBIO.NS cash_flow (annual, 2025-03-31) — Financing Cash Flow: -372041000.00
GUFICBIO.NS balance_sheet (annual, 2025-03-31) — Finished Goods: 530857000.00
GUFICBIO.NS balance_sheet (quarterly, 2025-03-31) — Finished Goods: 530857000.00
GUFICBIO.NS cash_flow (annual, 2025-03-31) — Free Cash Flow: 470425000.00
GUFICBIO.NS cash_flow (annual, 2025-03-31) — Gain Loss On Investment Securities: -1159000.00
GUFICBIO.NS cash_flow (annual, 2025-03-31) — Gain Loss On Sale Of PPE: 0.00
GUFICBIO.NS income_statement (annual, 2025-03-31) — General And Administrative Expense: 243758000.00
GUFICBIO.NS balance_sheet (annual, 2025-03-31) — Goodwill And Other Intangible Assets: 63443000.00
GUFICBIO.NS balance_sheet (quarterly, 2025-03-31) — Goodwill And Other Intangible Assets: 63443000.00
GUFICBIO.NS balance_sheet (annual, 2025-03-31) — Gross Accounts Receivable: 3217230000.00
GUFICBIO.NS balance_sheet (quarterly, 2025-03-31) — Gross Accounts Receivable: 3217230000.00
GUFICBIO.NS balance_sheet (annual, 2025-03-31) — Gross PPE: 6311077000.00
GUFICBIO.NS balance_sheet (quarterly, 2025-03-31) — Gross PPE: 6311077000.00
GUFICBIO.NS income_statement (annual, 2025-03-31) — Gross Profit: 4451048000.00
GUFICBIO.NS income_statement (quarterly, 2025-03-31) — Gross Profit: 1153525000.00
GUFICBIO.NS income_statement (annual, 2025-03-31) — Interest Expense: 231116000.00
GUFICBIO.NS income_statement (quarterly, 2025-03-31) — Interest Expense: 83998000.00
GUFICBIO.NS income_statement (annual, 2025-03-31) — Interest Expense Non Operating: 231116000.00
GUFICBIO.NS income_statement (quarterly, 2025-03-31) — Interest Expense Non Operating: 83998000.00
GUFICBIO.NS income_statement (annual, 2025-03-31) — Interest Income: 15737000.00
GUFICBIO.NS income_statement (annual, 2025-03-31) — Interest Income Non Operating: 15737000.00
GUFICBIO.NS cash_flow (annual, 2025-03-31) — Interest Paid Cff: -230283000.00
GUFICBIO.NS cash_flow (annual, 2025-03-31) — Interest Received Cfi: 9318000.00
GUFICBIO.NS balance_sheet (annual, 2025-03-31) — Inventory: 2168690000.00
GUFICBIO.NS balance_sheet (quarterly, 2025-03-31) — Inventory: 2168690000.00
GUFICBIO.NS balance_sheet (annual, 2025-03-31) — Invested Capital: 9114514000.00
GUFICBIO.NS balance_sheet (quarterly, 2025-03-31) — Invested Capital: 9114514000.00
GUFICBIO.NS cash_flow (annual, 2025-03-31) — Investing Cash Flow: -707773000.00
GUFICBIO.NS balance_sheet (annual, 2025-03-31) — Investmentin Financial Assets: 17843000.00
GUFICBIO.NS balance_sheet (quarterly, 2025-03-31) — Investmentin Financial Assets: 17843000.00
GUFICBIO.NS cash_flow (annual, 2025-03-31) — Issuance Of Capital Stock: 0.00
GUFICBIO.NS cash_flow (annual, 2025-03-31) — Issuance Of Debt: 168036000.00
GUFICBIO.NS balance_sheet (annual, 2025-03-31) — Land And Improvements: 103900000.00
GUFICBIO.NS balance_sheet (quarterly, 2025-03-31) — Land And Improvements: 103900000.00
GUFICBIO.NS balance_sheet (annual, 2025-03-31) — Long Term Capital Lease Obligation: 195933000.00
GUFICBIO.NS balance_sheet (quarterly, 2025-03-31) — Long Term Capital Lease Obligation: 195933000.00
GUFICBIO.NS balance_sheet (annual, 2025-03-31) — Long Term Debt: 1304996000.00
GUFICBIO.NS balance_sheet (quarterly, 2025-03-31) — Long Term Debt: 1304996000.00
GUFICBIO.NS balance_sheet (annual, 2025-03-31) — Long Term Debt And Capital Lease Obligation: 1500929000.00
GUFICBIO.NS balance_sheet (quarterly, 2025-03-31) — Long Term Debt And Capital Lease Obligation: 1500929000.00
GUFICBIO.NS cash_flow (annual, 2025-03-31) — Long Term Debt Payments: -235468000.00
GUFICBIO.NS balance_sheet (annual, 2025-03-31) — Long Term Provisions: 174916000.00
GUFICBIO.NS balance_sheet (quarterly, 2025-03-31) — Long Term Provisions: 174916000.00
GUFICBIO.NS balance_sheet (annual, 2025-03-31) — Machinery Furniture Equipment: 3966856000.00
GUFICBIO.NS balance_sheet (quarterly, 2025-03-31) — Machinery Furniture Equipment: 3966856000.00
GUFICBIO.NS balance_sheet (annual, 2025-03-31) — Minority Interest: 0.00
GUFICBIO.NS balance_sheet (quarterly, 2025-03-31) — Minority Interest: 0.00
GUFICBIO.NS income_statement (annual, 2025-03-31) — Minority Interests: 8000.00
GUFICBIO.NS income_statement (quarterly, 2025-03-31) — Minority Interests: 0.00
GUFICBIO.NS cash_flow (annual, 2025-03-31) — Net Business Purchase And Sale: 12000.00
GUFICBIO.NS cash_flow (annual, 2025-03-31) — Net Common Stock Issuance: 0.00
GUFICBIO.NS balance_sheet (annual, 2025-03-31) — Net Debt: 2946513000.00
GUFICBIO.NS balance_sheet (quarterly, 2025-03-31) — Net Debt: 2946513000.00
GUFICBIO.NS income_statement (annual, 2025-03-31) — Net Income: 696495000.00
GUFICBIO.NS income_statement (quarterly, 2025-03-31) — Net Income: 77195000.00
GUFICBIO.NS income_statement (annual, 2025-03-31) — Net Income Common Stockholders: 696495000.00
GUFICBIO.NS income_statement (quarterly, 2025-03-31) — Net Income Common Stockholders: 77195000.00
GUFICBIO.NS income_statement (annual, 2025-03-31) — Net Income Continuous Operations: 696487000.00
GUFICBIO.NS income_statement (quarterly, 2025-03-31) — Net Income Continuous Operations: 77195000.00
GUFICBIO.NS income_statement (annual, 2025-03-31) — Net Income From Continuing And Discontinued Operation: 696495000.00
GUFICBIO.NS income_statement (quarterly, 2025-03-31) — Net Income From Continuing And Discontinued Operation: 77195000.00
GUFICBIO.NS income_statement (annual, 2025-03-31) — Net Income From Continuing Operation Net Minority Interest: 696495000.00
GUFICBIO.NS income_statement (quarterly, 2025-03-31) — Net Income From Continuing Operation Net Minority Interest: 77195000.00
GUFICBIO.NS cash_flow (annual, 2025-03-31) — Net Income From Continuing Operations: 696487000.00
GUFICBIO.NS income_statement (annual, 2025-03-31) — Net Income Including Noncontrolling Interests: 696487000.00
GUFICBIO.NS income_statement (quarterly, 2025-03-31) — Net Income Including Noncontrolling Interests: 77195000.00
GUFICBIO.NS income_statement (annual, 2025-03-31) — Net Interest Income: -231116000.00
GUFICBIO.NS income_statement (quarterly, 2025-03-31) — Net Interest Income: -83998000.00
GUFICBIO.NS cash_flow (annual, 2025-03-31) — Net Investment Purchase And Sale: 0.00
GUFICBIO.NS cash_flow (annual, 2025-03-31) — Net Issuance Payments Of Debt: -67432000.00
GUFICBIO.NS cash_flow (annual, 2025-03-31) — Net Long Term Debt Issuance: 168036000.00
GUFICBIO.NS income_statement (annual, 2025-03-31) — Net Non Operating Interest Income Expense: -231116000.00
GUFICBIO.NS income_statement (quarterly, 2025-03-31) — Net Non Operating Interest Income Expense: -83998000.00
GUFICBIO.NS cash_flow (annual, 2025-03-31) — Net Other Investing Changes: -9517000.00
GUFICBIO.NS balance_sheet (annual, 2025-03-31) — Net PPE: 5246931000.00
GUFICBIO.NS balance_sheet (quarterly, 2025-03-31) — Net PPE: 5246931000.00
GUFICBIO.NS cash_flow (annual, 2025-03-31) — Net PPE Purchase And Sale: -707586000.00
GUFICBIO.NS cash_flow (annual, 2025-03-31) — Net Short Term Debt Issuance: -235468000.00
GUFICBIO.NS balance_sheet (annual, 2025-03-31) — Net Tangible Assets: 5947325000.00
GUFICBIO.NS balance_sheet (quarterly, 2025-03-31) — Net Tangible Assets: 5947325000.00
GUFICBIO.NS balance_sheet (annual, 2025-03-31) — Non Current Deferred Revenue: 53736000.00
GUFICBIO.NS balance_sheet (quarterly, 2025-03-31) — Non Current Deferred Revenue: 53736000.00
GUFICBIO.NS balance_sheet (annual, 2025-03-31) — Non Current Deferred Taxes Liabilities: 77716000.00
GUFICBIO.NS balance_sheet (quarterly, 2025-03-31) — Non Current Deferred Taxes Liabilities: 77716000.00
GUFICBIO.NS balance_sheet (annual, 2025-03-31) — Non Current Prepaid Assets: 118035000.00
GUFICBIO.NS balance_sheet (quarterly, 2025-03-31) — Non Current Prepaid Assets: 118035000.00
GUFICBIO.NS income_statement (annual, 2025-03-31) — Normalized EBITDA: 1383196000.00
GUFICBIO.NS income_statement (quarterly, 2025-03-31) — Normalized EBITDA: 267681000.00
GUFICBIO.NS income_statement (annual, 2025-03-31) — Normalized Income: 696495000.00
GUFICBIO.NS income_statement (quarterly, 2025-03-31) — Normalized Income: 77195000.00
GUFICBIO.NS cash_flow (annual, 2025-03-31) — Operating Cash Flow: 1225680000.00
GUFICBIO.NS income_statement (annual, 2025-03-31) — Operating Income: 1136284000.00
GUFICBIO.NS income_statement (quarterly, 2025-03-31) — Operating Income: 185301000.00
GUFICBIO.NS income_statement (annual, 2025-03-31) — Operating Revenue: 8198059000.00
GUFICBIO.NS income_statement (quarterly, 2025-03-31) — Operating Revenue: 2050201000.00
GUFICBIO.NS balance_sheet (annual, 2025-03-31) — Ordinary Shares Number: 100277506.00
GUFICBIO.NS balance_sheet (quarterly, 2025-03-31) — Ordinary Shares Number: 100277506.00
GUFICBIO.NS cash_flow (annual, 2025-03-31) — Other Cash Adjustment Outside Changein Cash: -1000.00
GUFICBIO.NS balance_sheet (annual, 2025-03-31) — Other Current Assets: 1914000.00
GUFICBIO.NS balance_sheet (quarterly, 2025-03-31) — Other Current Assets: 1914000.00
GUFICBIO.NS balance_sheet (annual, 2025-03-31) — Other Current Liabilities: 231144000.00
GUFICBIO.NS balance_sheet (quarterly, 2025-03-31) — Other Current Liabilities: 231144000.00
GUFICBIO.NS balance_sheet (annual, 2025-03-31) — Other Equity Interest: 1041000.00
GUFICBIO.NS balance_sheet (quarterly, 2025-03-31) — Other Equity Interest: 1041000.00
GUFICBIO.NS balance_sheet (annual, 2025-03-31) — Other Intangible Assets: 63443000.00
GUFICBIO.NS balance_sheet (quarterly, 2025-03-31) — Other Intangible Assets: 63443000.00
GUFICBIO.NS cash_flow (annual, 2025-03-31) — Other Non Cash Items: 227404000.00
GUFICBIO.NS balance_sheet (annual, 2025-03-31) — Other Non Current Assets: 2000.00
GUFICBIO.NS balance_sheet (quarterly, 2025-03-31) — Other Non Current Assets: 2000.00
GUFICBIO.NS balance_sheet (annual, 2025-03-31) — Other Non Current Liabilities: 1000.00
GUFICBIO.NS balance_sheet (quarterly, 2025-03-31) — Other Non Current Liabilities: 1000.00
GUFICBIO.NS income_statement (annual, 2025-03-31) — Other Non Operating Income Expenses: 36265000.00
GUFICBIO.NS income_statement (quarterly, 2025-03-31) — Other Non Operating Income Expenses: 3945000.00